Bill C-324 (Historical)

An Act to amend the Controlled Drugs and Substances Act (production of or trafficking in substances)

This bill is from the 42nd Parliament, 1st session, which ended in September 2019.

Sponsor

Introduced as a private member’s bill. (These don’t often become law.)

Status

Outside the Order of Precedence (a private member's bill that hasn't yet won the draw that determines which private member's bills can be debated), as of Dec. 1, 2016
(This bill did not become law.)

Summary

This is from the published bill.

This enactment amends the Controlled Drugs and Substances Act in order to prohibit the possession, production, sale or importation of anything if it is known that it will be used in the production or traffic of certain substances included in Schedule I to that Act.

Elsewhere

All sorts of information on this bill is available at LEGISinfo, an excellent resource from the Library of Parliament. You can also read the full text of the bill.

Bill numbers are reused for different bills each new session. Perhaps you were looking for one of these other C-324s:

C-324 (2023) An Act to amend the Special Economic Measures Act

C-324 (2013) An Act to amend the Employment Insurance Act (sickness benefits)

C-324 (2011) An Act to amend the Employment Insurance Act (sickness benefits)

C-324 (2010) An Act to amend the Competition Act and the Food and Drugs Act (child protection against advertising exploitation)

C-324 (2009) An Act to amend the Competition Act and the Food and Drugs Act (child protection against advertising exploitation)

C-324 (2007) An Act to change the name of the electoral district of Welland

Other House mentions

Procedure and House AffairsCommittees of the HouseRoutine Proceedings

February 8th, 2017 / 3:10 p.m.

See context

Liberal

Larry Bagnell Liberal Yukon, YT

Mr. Speaker, I have the honour to present, in both official languages, the 21st report of the Standing Committee on Procedure and House Affairs. The committee advises that, pursuant to Standing Order 92(3)(a), the committee reports that it has concurred in the report of the Subcommittee on Private Members' Business arising that Bill C-324, An Act to amend the Controlled Drugs and Substances Act (production of or trafficking in substances) should be designated non-votable.